Eagle Pharmaceuticals Inc (EGRX)

NASDAQ
Currency in USD
Disclaimer
25.67
-0.38
(-1.46%)
Closed
25.67
0.00
(0.00%)
After Hours
Real-time Data
Day's Range
25.55
26.91
52 wk Range
23.87
52.22
Volume
168,798
Prev. Close
26.05
Open
26.18
Day's Range
25.55-26.91
52 wk Range
23.87-52.22
Volume
168,798
Average Vol. (3m)
160,554
1-Year Change
-45.73%
Shares Outstanding
13,016,645
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
33.00
Upside +28.55%

People Also Watch

Eagle Pharmaceuticals Inc News

Eagle Pharmaceuticals Inc Analysis

Eagle Pharmaceuticals Inc Company Profile

Eagle Pharmaceuticals, Inc. is a pharmaceutical company. The Company's products include Ryanodex, Bendeka, Belrapzo, Treakisym, Pemfexy, Barhemsys and Byfavo. Ryanodex is used for malignant hyperthermia. EP-4104 Ryanodex (dantrolene sodium) is used for the treatment of organophosphate exposure. Belrapzo, Bendeka and Treakisym are used for chronic lymphocytic leukemia and non-Hodgkin's lymphoma. Pemfexy is an IV-administered cancer agent indicated for locally advanced or metastatic non-small cell lung cancer and mesothelioma. Its oncology and CNS/metabolic critical care pipeline includes product candidates that addresses underserved therapeutic areas across multiple disease states. Its vasopressin is an A-rated generic alternative to Vasostrict, which is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines. It is engaged in clinical trials for CAL02, an approach to the treatment of severe bacterial pneumonia.

Employees
102